Found 6 matching trials
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
PHASE2This is a study to evaluate the safety and efficacy of Losmapimod in treati...
Location
University of California Irvine
Losmapimod Safety and Efficacy in COVID-19
PHASE3The therapeutic hypothesis for the use of losmapimod in COVID-19 disease is...
Location
University of California Irvine - Irvine Medical Center
A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging
PHASE2This study is being conducted to assess the potential anti-inflammatory eff...
Location
GSK Investigational Site
PK Study of IV Formulation of GW856553
PHASE1The purpose of this study is to evaluate the safety of an IV infusion of GW...
Location
GSK Investigational Site
Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets
PHASE1This is a study to assess the relative bioavailability and the effect of fo...
Location
PPD Phase I Clinic
A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)
PHASE2This is a single-arm, multicenter, open-label Phase II, proof-of-mechanism ...
Location
GSK Investigational Site